6. Tempur-Pedic International ( TPX) is a manufacturer, marketer of pillows with a market cap exceeding $3.4 billion. It sells its products under the Tempur and Tempur-Pedic brands in over 80 countries.

The company had ROA of 27.14% in the last 12 months, while total asset turnover ratio was 1.74. For the same period, ROE and ROCE were 252.47% and 71.14%, respectively. Currently, the stock is trading at 17.51 times earnings compared to the industry P/E of 20.74, data compiled by Bloomberg show.

For the 2011 third quarter, net sales increased 30% to $383.1 million from $295.8 million in the same quarter preceding year. The company reported net income of $61.9 million compared to $44.2 million in same period last year. EPS increased 45% to 90 cents during the third quarter from 62 cents in the same quarter of 2010. Globally, mattress sales increased 28% and pillow sales grew 12% during the quarter.

Recently, the company announced its board of directors increased the existing repurchase program by $80 million to a total $280 million. The company plans to add 100 jobs at its factory in Albuquerque and fill nearly 50% of the positions in 2012.

For full year 2011, the company expects net sales to range from $1.40 billion to $1.45 billion and sees EPS in the $3.12 to $3.17 per diluted share range.

Of the 15 analysts covering the stock, 73% recommend a buy and 27% rate a hold. There were no sell recommendations for the stock. Analysts polled by Bloomberg foresee the stock gaining an average 38.3% to $76.33 in the upcoming 12 months.

If you liked this article you might like

Teva Must Clear Three Big Hurdles to Reclaim Its Perch

Teva Shares Are Taking a Beating and Dragging Down the Generic Drugmakers

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Analysts' Actions -- Discovery, First Solar, Momenta, VF Corp. and More

Sarepta Leads Biotech Movers on Voucher Deal News